Critical appraisal of neuroprotection trials in head injury: What have we learned? (original) (raw)

• Kay A, Teasdale GM. Head injury in the United Kingdom.World J Surg 25: 1210–1220, 2001.
  Article PubMed CAS Google Scholar
• Narayan RK, Michael ME, The Clinical Trials in Head Injury Study Group. Clinical trials in head injury.J Neurotrauma 19: 503–557, 2002.
  Article PubMed Google Scholar
• Murray CJL, Lopez AD. Global mortality, disability and the contribution of the risk factors: global burden of disease study.Lancet 349: 1436–1442, 1997.
  Article PubMed CAS Google Scholar
• Bullock R, Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies.Neurosurgery 45: 207–220, 1999.
  Article PubMed CAS Google Scholar
• Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture.J Neurosci 7: 357–368, 1987.
  PubMed CAS Google Scholar
• Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury.Science 244: 798–800, 1989.
  Article PubMed CAS Google Scholar
• Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.Proc Natl Acad Sci USA 86: 9030–9033, 1989.
  Article PubMed CAS Google Scholar
• Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury.J Neurosci 17: 7415–7424, 1997.
  PubMed CAS Google Scholar
• Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.Science 263: 687–689, 1994.
  Article PubMed CAS Google Scholar
• Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.Proc Natl Acad Sci USA 96: 13978–13982, 1999.
  Article PubMed CAS Google Scholar
• Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A et al. NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase.J Neurosci 20: 8005–8011, 2000.
  PubMed CAS Google Scholar
• Bullock R, Kuroda Y, Teasdale GM, McCulloch J. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties.Acta Neurochir Suppl (Wien) 55: 49–55, 1992.
  CAS Google Scholar
• Choi DW. Calcium and excitotoxic neuronal injury.Ann NY Acad Sci 747: 162–171, 1994.
  Article PubMed CAS Google Scholar
• Unterberg A, Baethmann AJ. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: cerebral exposure to bradykinin and plasma.J Neurosurg 61: 87–96, 1984.
  Article PubMed CAS Google Scholar
• Maier-Hauff K, Baethmann AJ, Lange M, Schurer L, Unterberg A. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: studies on kinin formation in focal and perifocal brain tissue.J Neurosurg 61: 97–106, 1984.
  Article PubMed CAS Google Scholar
• Unterberg A, Dautermann C, Baethmann A, Muller-Esterl W. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: inhibition of the kallikrein-kinin system in traumatic brain swelling.J Neurosurg 64: 269–276, 1986.
  Article PubMed CAS Google Scholar
• Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.J Neurotrauma 16: 431–444, 1999.
  Article PubMed CAS Google Scholar
• Sahuquillo-Barris J, Lamarca-Ciuro J, Vilalta-Castan J, Rubio-Garcia E, Rodriguez-Pazos M. Acute subdural hematoma and diffuse axonal injury after severe head trauma.J Neurosurg 68: 894–900, 1988.
  Article PubMed CAS Google Scholar
• Gentleman SM, Roberts GW, Gennarelli TA, Maxwell WL, Adams JH, Kerr S et al. Axonal injury: a universal consequence of fatal closed head injury?Acta Neuropathol (Berl) 89: 537–543, 1995.
  Article CAS Google Scholar
• Reinert MM, Bullock R. Clinical trials in head injury.Neurol Res 21: 330–338, 1999.
  PubMed CAS Google Scholar
• Smith DH, Nonaka M, Miller R, Leoni M, Chen XH, Alsop D et al. Immediate coma following inertial brain injury dependent on axonal damage in the brainstem.J Neurosurg 93: 315–322, 2000.
  Article PubMed CAS Google Scholar
• Maxwell WL, Povlishock JT, Graham DL. A mechanistic analysis of nondisruptive axonal injury: a review.J Neurotrauma 14: 419–440, 1997.
  Article PubMed CAS Google Scholar
• Pettus EH, Christman CW, Giebel ML, Povlishock JT. Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change.J Neurotrauma 11: 507–522, 1994.
  Article PubMed CAS Google Scholar
• Okonkwo DO, Povlishock JT. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury.J Cereb Blood Flow Metab 19: 443–451, 1999.
  Article PubMed CAS Google Scholar
• Lifshitz J, Friberg H, Neumar RW, Raghupathi R, Welsh FA, Janmey P et al. Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus.J Cereb Blood Flow Metab 23: 219–231, 2003.
  Article PubMed CAS Google Scholar
• Tigranian RA, Promyslov MS. Peculiarities of oxidative phosphorylation in brain mitochondria with craniocerebral trauma.Ukr Biokhim Zh 41: 170–173, 1969.
  PubMed CAS Google Scholar
• Arai C, Ozawa K. Studies on the biochemical aspects of brain injuries and brain edema with special reference to functional changes of mitochondria in the brain.Shinkei Kenkyu No Shimpo 9: 611–622, 1965.
  PubMed CAS Google Scholar
• Bakay L, Lee JC, Lee GC, Peng JR. Experimental cerebral concussion. Part 1: an electron microscopic study.J Neurosurg 47: 525–531, 1977.
  Article PubMed CAS Google Scholar
• Yang MS, DeWitt DS, Becker DP, Hayes RL. Regional brain metabolite levels following mild experimental head injury in the cat.J Neurosurg 63: 617–621, 1985.
  Article PubMed CAS Google Scholar
• Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.Neuron 15: 961–973, 1995.
  Article PubMed CAS Google Scholar
• Uchino H, Elmer E, Uchino K, Lindvall O, Siesjo BK. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischemia in the rat.Acta Physiol Scand 155: 469–471, 1995.
  Article PubMed CAS Google Scholar
• Xiong Y, Gu Q, Peterson PL, Muizelaar JP, Lee CP. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury.J Neurotrauma 14: 23–34, 1997.
  Article PubMed CAS Google Scholar
• Clausen T, Zauner A, Levasseur JE, Rice AC, Bullock R. Induced mitochondrial failure in the feline brain: implications for understanding acute post-traumatic metabolic events.Brain Res 908: 35–48, 2001.
  Article PubMed CAS Google Scholar
• Verweij BH, Muizelaar JP, Vinas FC, Peterson PL, Xiong Y, Lee CP. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111).Neurol Res 19: 334–339, 1997.
  PubMed CAS Google Scholar
• Buki A, Okonkwo DO, Povlishock JT. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury.J Neurotrauma 16: 511–521, 1999.
  Article PubMed CAS Google Scholar
• Alessandri B, Rice AC, Levasseur J, DeFord M, Hamm RJ, Bullock MR. Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats.J Neurotrauma 19: 829–841, 2002.
  Article PubMed Google Scholar
• MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain.Neurosci Lett 164: 89–92, 1993.
  Article PubMed CAS Google Scholar
• Beilharz EJ, Williams CE, Dragunow M, Sirimanne ES, Gluckman PD. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss.Brain Res Mol Brain Res 29: 1–14, 1995.
  Article PubMed CAS Google Scholar
• Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E, McIntosh TK. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat.Am J Pathol 147: 1575–1583, 1995.
  PubMed CAS Google Scholar
• Buki A, Okonkwo DO, Wang KK, Povlishock JT. Cytochrome c release and caspase activation in traumatic axonal injury.J Neurosci 20: 2825–2834, 2000.
  PubMed CAS Google Scholar
• Sullivan PG, Keller JN, Bussen WL, Scheff SW. Cytochrome c release and caspase activation after traumatic brain injury.Brain Res 949: 88–96, 2002.
  Article PubMed CAS Google Scholar
• Yakovlev AG, Faden AI. Caspase-dependent apoptotic pathways in CNS injury.Mol Neurobiol 24: 131–144, 2001.
  Article PubMed CAS Google Scholar
• Bullock R, Zauner A, Myseros JS, Marmarou A, Woodward JJ, Young HF. Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events.Ann NY Acad Sci 765: 290–297, 1995.
  Article PubMed CAS Google Scholar
• Gopinath SP, Valadka AB, Goodman JC, Robertson CS. Extracellular glutamate and aspartate in head injured patients.Acta Neurochir Suppl 76: 437–438, 2000.
  PubMed CAS Google Scholar
• Tolias CM, Richards DA, Bowery NG, Sgouros S. Extracellular glutamate in the brains of children with severe head injuries: a pilot microdialysis study.Childs Nerv Syst 18: 368–374, 2002.
  PubMed Google Scholar
• Sarrafzadeh AS, Sakowitz OW, Callsen TA, Lanksch WR, Unterberg AW. Detection of secondary insults by brain tissue pO2 and bedside microdialysis in severe head injury.Acta Neurochir Suppl 81: 319–321, 2002.
  PubMed CAS Google Scholar
• Khaldi A, Chiueh CC, Bullock MR, Woodward JJ. The significance of nitric oxide production in the brain after injury.Ann NY Acad Sci 962: 53–59, 2002.
  Article PubMed CAS Google Scholar
• Silberstein M, Lane D, Dodd S, Opeskin K. Identification of a by-product of nitric oxide synthase activity in human acute brain injury with in vivo proton magnetic resonance spectroscopy.Am J Neuroradiol 23: 389–392, 2002.
  PubMed Google Scholar
• Kasprzak HA, Wozniak A, Drewa G, Wozniak B. Enhanced lipid peroxidation processes in patients after brain contusion.J Neurotrauma 18: 793–797, 2001.
  Article PubMed CAS Google Scholar
• Reinert M, Hoelper B, Doppenberg E, Zauner A, Bullock R. Substrate delivery and ionic balance disturbance after severe human head injury.Acta Neurochir Suppl 76: 439–444, 2000.
  PubMed CAS Google Scholar
• Hutchinson PJ, Gupta AK, Fryer TF, Al-Rawi PG, Chatfield DA, Coles JP et al. Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: a combined microdialysis and triple oxygen positron emission tomography study.J Cereb Blood Flow Metab 22: 735–745, 2002.
  Article PubMed Google Scholar
• Robertson CS. Management of cerebral perfusion pressure after traumatic brain injury.Anesthesiology 95: 1513–1517, 2001.
  Article PubMed CAS Google Scholar
• Steiner LA, Czosnyka M, Piechnik SK, Smielewski P, Chatfield D, Menon DK et al. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury.Crit Care Med 30: 733–738, 2002.
  Article PubMed Google Scholar
• Czosnyka M, Smielewski P, Piechnik S, Steiner LA, Pickard JD. Cerebral autoregulation following head injury.J Neurosurg 95: 756–763, 2001.
  Article PubMed CAS Google Scholar
• Eker C, Asgeirsson B, Grande PO, Schalen W, Nordstrom CH. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation.Crit Care Med 26: 1881–1886, 1998.
  Article PubMed CAS Google Scholar
• Povlishock JT, Hayes RL, Michel ME, McIntosh TK. Workshop on animal models of traumatic brain injury.J Neurotrauma 11: 723–732, 1994.
  Article PubMed CAS Google Scholar
• Statler KD, Jenkins LW, Dixon CE, Claek RS, Marion DW, Kochanek PM. The simple model versus the super model: translating experimental traumatic brain injury research to the bedside.J Neurotrauma 18: 1195–1206, 2001.
  Article PubMed CAS Google Scholar
• Faden AI. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition.Curr Opin Neurol 15: 707–712, 2002.
  Article PubMed Google Scholar
• Bramlett HM, Dietrich WD. Neuropathological protection after traumatic brain injury in intact female rats versus males or ovariectomized females.J Neurotrauma 18: 891–900, 2001.
  Article PubMed CAS Google Scholar
• Farin A, Deutsch R, Biegon A, Marshall LF. Sex-related differences in patients with severe head injury: greater susceptibility to brain swelling in female patients 50 years of age and younger.J Neurosurg 98: 32–36, 2003.
  Article PubMed Google Scholar
• Alves OL, Doyle A, Gilman C, Sarkar M, Young HF, Bullock R. Evaluation of topiramate neuroprotective effect in severe TBI by using microdialysis. Abstract of oral presentation at AANS Meeting, San Diego, 2003.J Neurosurg 98: 712, 2003.
  Google Scholar
• Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomized controlled trials in head injury: review of published studies.Br Med J 320: 1308–1311, 2000.
  Article CAS Google Scholar
• MRC CRASH Trial National Coordinators. Update on progress in the international multicenter, randomized, controlled trial of corticosteroids after significant head injury (Medical Research Council CRASH Trial).Curr Opin Crit Care 9: 92–97, 2003.
  Article Google Scholar
• Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr et al. Lack of effect of induction of hypothermia after acute brain injury.N Engl J Med 344: 556–563, 2001.
  Article PubMed CAS Google Scholar
• Hukkelhoven CW, Steyerberg EW, Farace E, Habbema JD, Marshall LF, Maas AI. Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials.J Neurosurg 97: 549–557, 2002.
  Article PubMed Google Scholar
• Clifton GL, Choi SC, Miller ER, Levin HS, Smith KR Jr, Muizelaar JP et al. Intercenter variance in clinical trials of head trauma-experience of the National Acute Brain Injury Study: Hypothermia.J Neurosurg 95: 751–755, 2001.
  Article PubMed CAS Google Scholar
• Marshall LF. Intercenter variance.J Neurosurg 95: 733–734, 2001.
  Article PubMed CAS Google Scholar
• Teasdale GM. Comment on Bullock R, Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies.Neurosurgery 45: 207–220, 1999.
  Article Google Scholar
• Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration.Mic Res Tech 60: 614–632, 2003.
  Article CAS Google Scholar
• Anderson RE, Hansson LO, Nilsson O, Liska J, Settegren G. High serum S100B levels for trauma patients without head injuries.Neurosurgery 48: 1255–1260, 2001.
  PubMed CAS Google Scholar
• Alderson P, Roberts I. Corticosteroids in acute traumatic brain injury: systematic review of randomized controlled trials.Br Med J 314: 1855–1859, 1997.
  CAS Google Scholar
• Grumme T, Baethmann A, Kolodziejczyk D, Krimmer J, Fischer M, von Eisenhart Rothe B et al. Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases.Res Exp Med (Berl) 195: 217–229, 1995.
  Article CAS Google Scholar
• Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.J Neurosurg 89: 519–525, 1998.
  Article PubMed CAS Google Scholar
• Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.J Neurotrauma 16: 431–444, 1999.
  Article PubMed CAS Google Scholar
• Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport ZH et al. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial.Crit Care Med 30: 548–554, 2002.
  Article PubMed CAS Google Scholar
• Robertson CS, Valadka AB, Hannay HJ, Contant CF, Gopinath SP, Cormio M et al. Prevention of secondary ischemic insults after severe head injury.Crit Care Med 27: 2086–2095, 1999.
  Article PubMed CAS Google Scholar
• Mauler F, Mittendorf J, Horvath E, De Vry J. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.J Pharmacol Exp Ther 302: 359–368, 2002.
  Article PubMed CAS Google Scholar
• Fumoto N, Nakatsuka H, Ohta S, Kumon Y, Ohnishi T. Hippocampal CA1 neuron survival and cytosolic FKBP12, the 12 kDa FK506-binding protein, after ischemia and tacrolimus treatment in gerbils.Neurosci Lett 339: 219–222, 2003.
  Article PubMed CAS Google Scholar
• Jackson PF, Tays KL, Maclin KM, Ko YS, Li W, Vitharana D et al. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors.J Med Chem 44: 4170–4175, 2001.
  Article PubMed CAS Google Scholar